Recurrent glioblastoma: ongoing clinical challenges and future prospects

E Pineda, M Domenech, A Hernández… - OncoTargets and …, 2023 - Taylor & Francis
Virtually all glioblastomas treated in the first-line setting will recur in a short period of time,
and the search for alternative effective treatments has so far been unsuccessful. Various …

Subcellular structure, heterogeneity, and plasticity of senescent cells

TC Bitencourt, JE Vargas, AO Silva, LR Fraga… - Aging …, 2024 - Wiley Online Library
Cellular senescence is a state of permanent growth arrest. It can be triggered by telomere
shortening (replicative senescence) or prematurely induced by stresses such as DNA …

Magnetic and GRPR-targeted reduced graphene oxide/doxorubicin nanocomposite for dual-targeted chemo-photothermal cancer therapy

BS Dash, YJ Lu, HA Chen, CC Chuang… - Materials Science and …, 2021 - Elsevier
Herein, we design a rGO-based magnetic nanocomposite by decorating rGO with citrate-
coated magnetic nanoparticles (CMNP). The magnetic rGO (mrGO) was modified by …

[HTML][HTML] Obesity drives adipose-derived stem cells into a senescent and dysfunctional phenotype associated with P38MAPK/NF-KB axis

LK Grun, RM Maurmann, JN Scholl, ME Fogaça… - Immunity & …, 2023 - Springer
Background Adipose-derived stem cells (ADSC) are multipotent cells implicated in tissue
homeostasis. Obesity represents a chronic inflammatory disease associated with metabolic …

Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements

L Baratto, H Duan, R Laudicella, A Toriihara… - European Journal of …, 2020 - Springer
Aim 68 Ga-RM2 is a bombesin (BBN) analog that targets the gastrin releasing peptide
receptors (GRPR) overexpressed in many cancer cells, including prostate cancer (PC). It …

[HTML][HTML] Bombesin receptor family activation and CNS/neural tumors: review of evidence supporting possible role for novel targeted therapy

TW Moody, L Lee, I Ramos-Alvarez… - Frontiers in …, 2021 - frontiersin.org
G-protein-coupled receptors (GPCRs) are increasingly being considered as possible
therapeutic targets in cancers. Activation of GPCR on tumors can have prominent growth …

A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC)

JW Hwang, J Loisel-Duwattez, C Desterke… - … et Biophysica Acta (BBA …, 2020 - Elsevier
Background Current experimental models using either human or mouse cell lines, are not
representative of the complex features of GBM. In particular, there is no model to study …

Combined treatments with a retinoid receptor agonist and epigenetic modulators in human neuroblastoma cells

VR Almeida, IA Vieira, M Buendia, AT Brunetto… - Molecular …, 2017 - Springer
Neuroblastoma (NB) is the most common extracranial solid childhood tumor accounting for
around 15% of pediatric cancer deaths and most probably originates from a failure in the …

Therapeutic perspective of temozolomide resistance in glioblastoma treatment

Q Xia, L Liu, Y Li, P Zhang, D Han, L Dong - Cancer Investigation, 2021 - Taylor & Francis
Glioblastoma (GB) is the most lethal form of primary brain neoplasm. TMZ is the first-line
standard treatment, but the strong resistance constrains the efficacy in clinical use. GB …

Recent insights into biological functions of mammalian bombesin-like peptides and their receptors

X Qu, H Wang, R Liu - Current Opinion in Endocrinology …, 2018 - journals.lww.com
Several important biological roles of BLPs and their receptors in nervous system were
identified. Together with researches regarding central roles of BLPs, studies revealing the …